Executive Order 13139: Improving Health Protection of Military Personnel Participating in Particular Military Operations

President: Bill Clinton

Set strict consent, notice, review and presidential-waiver rules for investigational or unapproved-use medical products in military operations.

Status: In effect. Is Executive Order 13139 still in effect? Yes. Executive Order 13139 remains in effect. See Federal Register record.

What does Executive Order 13139 do?

EO 13139 implements 10 U.S.C. 1107 for military use of investigational drugs or drugs unapproved for the intended use. DoD must ordinarily obtain informed consent, give extensive notice and training, track recipients and involve FDA. Only the President may waive consent after a written Defense request, and the order sets demanding necessity and risk criteria. The order remains reproduced with the current statute and in DoD force-health-protection policy.

Administration position: The order permits exceptional use under safeguards; it does not provide a general power to administer experimental products without consent.
SignedSeptember 30, 1999
Default rulePrior informed consent
Waiver authorityPresident only
Statutory authority named10 U.S.C. 1107

Authority labels repeat this guide’s cited legal analysis. How authority is labeled →

Before and after

Before the order

Congress had required notice and reserved waiver authority to the President but implementation standards needed specification.

After the order

DoD received a formal process for consent, presidential waiver requests, FDA involvement, tracking and follow-up.

Who had to do what

Agency / officeActionTiming / position
Defense SecretaryAssess threats and seek approval or a presidential waiver when necessaryContinuing
PresidentDecide any informed-consent waiverCase-specific
FDA CommissionerProvide regulatory review and assistanceContinuing
DoDNotify, train, track and monitor affected personnelContinuing

What happened next

EO 13139 established the implementation framework.